Table 3 Count of patients with elevated hs-cTnT between 2019 and 2021
2019 (n = 1236) | 2020 (n = 1669) | 2021 (n = 1682) | Total (n = 4587) | |
|---|---|---|---|---|
NCA | 832 (67.3%) | 1227 (73.5%) | 1171 (69.6%) | 3230 (70.4%) |
DCA | 205 (16.6%) | 242 (14.5%) | 258 (15.3%) | 705 (15.4%) |
PCI | 199 (16.1%) | 200 (12.0%) | 253 (15.0%) | 652 (14.2%) |